Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association's 34ᵗʰ International Symposium on ALS/MND
BOTHELL, Wash., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. ATHA, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that a symposium presentation highlighting data from preclinical…
#bothell #wash #athirapharma #als #mnd #basel #switzerland #kevinchurch #phd #hgf